Q32 Bio Inc.

QTTB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$47,733-$53,743-$42,809-$95,764
Dep. & Amort.$487$499$370$9,544
Deferred Tax$0$0$2,425$0
Stock-Based Comp.$4,386$0$1,238$0
Change in WC-$9,637$26,315$26,943-$41,803
Other Non-Cash-$15,218$8,252$876$18,272
Operating Cash Flow-$67,715-$18,677-$10,957-$109,751
Investing Activities
PP&E Inv.-$75-$5-$2,485-$2,396
Net Acquisitions$0$0$130,000$0
Inv. Purchases$0$0-$157,460-$97,392
Inv. Sales/Matur.$20,000$0$65,461$49,000
Other Inv. Act.$0$0-$37,982$0
Investing Cash Flow$19,925-$5-$2,466-$50,788
Financing Activities
Debt Repay.$7,000$300$30,000$0
Stock Issued$42,000$106$69$52,169
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$46,138$0$0$0
Financing Cash Flow$95,138$406$30,069$52,169
Forex Effect$0$9,907$0-$679
Net Chg. in Cash$47,348-$8,369$16,646-$109,049
Supplemental Information
Beg. Cash$31,264$33,986$32,894$217,431
End Cash$78,612$25,617$49,540$108,382
Free Cash Flow-$67,790-$18,682-$13,442-$112,147